Home›Search›Expert Opinion on Orphan Drugs

Expert Opinion on Orphan Drugs

Taylor and Francis Ltd. · United Kingdom · Est. 2012

ISSN2167-8707

SJR Q2✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 50% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.392

H-Indexi

SNIPi

0.359

Total Worksi

862

Total Citationsi

5,258

2yr Mean Citednessi

11.40

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope

Subject areas: Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Health Policy; Pharmacology (medical).

General Information

Country / RegionUnited Kingdom

Primary Language—

1st Year Published2012

Annual Volume~ 5 articles / year

StatusActive (last: 2024)

Total Publications862

Publisher OrgTaylor & Francis

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

5/11 · 45%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2167-8707

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

625

2017

520

2018

262

2019

286

2020

141

2021

2022

2023

2024

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q2

Health PolicyQ3

Pharmacology (medical)Q3

Subject Classification

Scopus Categories

Pharmacology (medical)Health PolicyPharmacology, Toxicology and Pharmaceutics (miscellaneous)

Research Topics (OpenAlex)

Lysosomal Storage Disorders ResearchGenomics and Rare DiseasesHealth Systems, Economic Evaluations, Quality of LifeLymphoma Diagnosis and TreatmentDiverse Scientific and Economic StudiesChronic Lymphocytic Leukemia ResearchNeurogenetic and Muscular Disorders ResearchHuman auditory perception and evaluationEducational Robotics and EngineeringPharmaceutical Economics and Policy

Frequently asked questions about Expert Opinion on Orphan Drugs

Is Expert Opinion on Orphan Drugs a predatory journal?

PubScope has no integrity flags on record for Expert Opinion on Orphan Drugs: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Expert Opinion on Orphan Drugs?

Expert Opinion on Orphan Drugs is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.392.

Is Expert Opinion on Orphan Drugs indexed in Scopus and Web of Science?

Expert Opinion on Orphan Drugs is indexed in Scopus.

What is the aims and scope of Expert Opinion on Orphan Drugs?